Helen Ullrich1, Thomas Münzel, Tommaso Gori. 1. Cardiology Center, Cardiology I, Universitiy Medical Center, Johannes Gutenberg University Mainz,German Center of Cardiovascular Research (Deutsches Zentrum für Herz-Kreislauf-Forschung,DZHK), Rhine-Main.
Abstract
BACKGROUND: Stent thrombosis (ST) is a dreaded complication after stent implantation and is associated with a mortality between 5% and 45%. The mechanisms by which ST arises are complex. Because of the seriousness of this situation, all phy - sicians should have at least basic knowledge of it. In this article, we present the risk factors for ST and discuss some innovative approaches to its treatment. METHODS: This review is based on pertinent articles retrieved by a selective search in PubMed, and on current international guidelines and expert recommendations. RESULTS: The frequency of ST has been markedly lowered by technical advances in coronary stenting and by the implementation of modern implantation techniques, including the introduction of coverage with dual antiplatelet therapy (DAPT). Both patient-related risk factors and procedural aspects can elevate the risk of ST. The independent risk factors for ST include premature termination of DAPT (hazard ratio [HR] 26.8; 95% confidence interval [8.4; 85.4]; p <0.0001), malignant disease (odds ratio [OR]: 17.45; [4.67; 65.26]; p <0.0001), and diabetes mellitus (OR: 3.14; [1.33; 7.45]; p = 0.0093). In comparison to angiographically guided procedures, the use of intracoronary imaging techniques in patients with acute coronary syndrome lowers the frequency of ST (0.6% versus 1.2%; p = 0.005). These techniques enable the detection of many findings in the coronary arteries that are associated with the development of ST. In such cases, countermeasures such as secondary stent dilatation or prolongation of DAPT can help prevent ST. CONCLUSION: As the pathophysiology of ST is multifactorial, research in this area presents a special challenge. Prospective clinical trials will be needed to determine whether the systematic use of imaging techniques can lower the frequency of ST.
BACKGROUND: Stent thrombosis (ST) is a dreaded complication after stent implantation and is associated with a mortality between 5% and 45%. The mechanisms by which ST arises are complex. Because of the seriousness of this situation, all phy - sicians should have at least basic knowledge of it. In this article, we present the risk factors for ST and discuss some innovative approaches to its treatment. METHODS: This review is based on pertinent articles retrieved by a selective search in PubMed, and on current international guidelines and expert recommendations. RESULTS: The frequency of ST has been markedly lowered by technical advances in coronary stenting and by the implementation of modern implantation techniques, including the introduction of coverage with dual antiplatelet therapy (DAPT). Both patient-related risk factors and procedural aspects can elevate the risk of ST. The independent risk factors for ST include premature termination of DAPT (hazard ratio [HR] 26.8; 95% confidence interval [8.4; 85.4]; p <0.0001), malignant disease (odds ratio [OR]: 17.45; [4.67; 65.26]; p <0.0001), and diabetes mellitus (OR: 3.14; [1.33; 7.45]; p = 0.0093). In comparison to angiographically guided procedures, the use of intracoronary imaging techniques in patients with acute coronary syndrome lowers the frequency of ST (0.6% versus 1.2%; p = 0.005). These techniques enable the detection of many findings in the coronary arteries that are associated with the development of ST. In such cases, countermeasures such as secondary stent dilatation or prolongation of DAPT can help prevent ST. CONCLUSION: As the pathophysiology of ST is multifactorial, research in this area presents a special challenge. Prospective clinical trials will be needed to determine whether the systematic use of imaging techniques can lower the frequency of ST.
Authors: Ziad A Ali; Runlin Gao; Takeshi Kimura; Yoshinobu Onuma; Dean J Kereiakes; Stephen G Ellis; Bernard Chevalier; Minh-Thien Vu; Zhen Zhang; Charles A Simonton; Patrick W Serruys; Gregg W Stone Journal: Circulation Date: 2017-10-31 Impact factor: 29.690
Authors: Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferovic; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala Journal: Eur Heart J Date: 2019-01-07 Impact factor: 29.983
Authors: Fabrizio D'Ascenzo; Mario Bollati; Fabrizio Clementi; Davide Castagno; Bo Lagerqvist; Jose M de la Torre Hernandez; Juriën M ten Berg; Bruce R Brodie; Philip Urban; Lisette Okkels Jensen; Gabriel Sardi; Ron Waksman; John M Lasala; Stefanie Schulz; Gregg W Stone; Flavio Airoldi; Antonio Colombo; Gilles Lemesle; Robert J Applegate; Piergiovanni Buonamici; Ajay J Kirtane; Anetta Undas; Imad Sheiban; Fiorenzo Gaita; Giuseppe Sangiorgi; Maria Grazia Modena; Giacomo Frati; Giuseppe Biondi-Zoccai Journal: Int J Cardiol Date: 2012-02-22 Impact factor: 4.164
Authors: A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm Journal: N Engl J Med Date: 1996-04-25 Impact factor: 91.245
Authors: George D Dangas; Bimmer E Claessen; Roxana Mehran; Ke Xu; Martin Fahy; Helen Parise; José P S Henriques; E Magnus Ohman; Harvey D White; Gregg W Stone Journal: JACC Cardiovasc Interv Date: 2012-11 Impact factor: 11.195